65219-632-20 · Ropivacaine Hydrochloride Injection · Fresenius Kabi USA, LLC
What is the status for 65219-632-20 · Ropivacaine Hydrochloride Injection · Fresenius Kabi USA, LLC?
For 65219-632-20, generic name is Ropivacaine Hydrochloride Injection; manufacturer is Fresenius Kabi USA, LLC; status is Current; availability now is Available; initial posting date is 03/23/2018, recorded from its source on 2026-11-04.
"initial_posting_date": "03/23/2018", "package_ndc": "65219-632-20", "generic_name": "Ropivacaine Hydrochloride Injection", "contact_info": "888-386-1300", "availability": "Available"
— api.fda.gov, retrieved 2026-11-04
- Package NDC
- 65219-632-20 verified
- Generic name
- Ropivacaine Hydrochloride Injection verified
- Manufacturer
- Fresenius Kabi USA, LLC verified
- Status
- Current verified
- Availability now
- Available verified
- Initial posting date
- 03/23/2018 verified
- Last update date
- 11/03/2026 verified
- Days in shortage
- 3148 our reading
- Dosage form
- Injection verified
- Therapeutic category
- Anesthesia verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Dosage form and Therapeutic category
"update_date": "11/03/2026", "therapeutic_category": [ "Anesthesia" ], "dosage_form": "Injection", "presentation": "Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20)", "company_name": "Fresenius Kabi USA, LLC", "status": "Current"
— all from api.fda.gov, retrieved 2026-11-04
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000